Seres therapeutics to participate in cowen 44th annual healthcare conference

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb), a leading microbiome therapeutics company, announced today that eric shaff, president and chief executive officer of seres therapeutics, will participate in a panel discussion at the cowen 44th annual health care conference on wednesday, march 6, 2024 at 9:10 a.m. et. an audio webcast of the panel discussion will be available under the “investors and news” section of seres' website. a replay of the presentation will bec.
MCRB Ratings Summary
MCRB Quant Ranking